MTOR and renal cell carcinoma: Accordingly, the purpose of this study is to investigate the impact of molecular target agents on the tumor stroma of RCC and examine the efficacy of combination therapy with an mTOR inhibitor and a multiple‐tyrosine kinase inhibitor.